Puridify $1.42m seed round is co-led by Imperial Innovations and SR One, and matched with public funds.
Puridify, a UCL spin-out based in London, has secured £850,000 ($1.42m) in a seed funding round co-led by Imperial Innovations, the technology transfer company of Imperical College London, and SR One, GlaxoSmithKline’s venture capital fund. UCL Business, the technology transfer office of University College London, also invested.
Purifidy also managed to attract matched-funding awards from the Technology Strategy Board, the UK government’s innovation agency, totalling £780,000 ($1.3m).
The spin-out is based on technology developed at the Advanced Centre for Biochemical…
